Phenotypic Variation in Hyperandrogenic Women Influences the Findings of Abnormal Metabolic and Cardiovascular Risk Parameters
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
In hyperandrogenic women, several phenotypes may be observed. This includes women with classic polycystic ovary syndrome (C-PCOS), those with ovulatory (OV) PCOS, and women with idiopathic hyperandrogenism (IHA), which occurs in women with normal ovaries. Where other causes have been excluded, we categorized 290 hyperandrogenic women who were seen consecutively for this complaint between 1993 and 2004 into these three subgroups. The aim was to compare the prevalence of obesity, insulin resistance, and dyslipidemia as well as increases in C-reactive protein and homocysteine in these different phenotypes with age-matched ovulatory controls of normal weight (n = 85) and others matched for body mass index (BMI) with women with C-PCOS (n = 42). Although BMI affected fasting serum insulin and the Quantitative Insulin-Sensitivity Check Index, these markers of insulin resistance were greatest in C-PCOS (n = 204), followed by OV-PCOS (n = 50) and then IHA (n = 33). Androgen levels were similar in OV-PCOS and IHA but were higher in C-PCOS, whereas gonadotropins were similar in all groups. Lipid abnormalities were highest in C-PCOS and OV-PCOS and were normal in IHA. C-reactive protein was elevated in C-PCOS and OV-PCOS but not IHA. Homocysteine was elevated only in C-PCOS. Overall, the prevalence of obesity (BMI > 30) was 29% in C-PCOS, 8% in OV-PCOS, and 15% in IHA and insulin resistance (Quantitative Insulin-Sensitivity Check Index < 0.33) was 68% in C-PCOS, 36% in OV-PCOS, and 26% in IHA. The prevalence of having at least one elevated cardiovascular risk marker was 45% in C-PCOS 38% in OV-PCOS and was not increased on IHA (6%). These results suggest that among hyperandrogenic women the prevalence of abnormal metabolic and cardiovascular risk parameters is greatest in C-PCOS, followed by OV-PCOS and then women with IHA. Moreover, in that in OV-PCOS and IHA, ages and weights were similar yet the prevalence of metabolic and cardiovascular risk was greater in OV-PCOS, the finding of polycystic ovaries may be a significant modifying factor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 8×
“The following criteria were considered as being abnormal: obesity, BMI 30 or more; insulin resistance, QUICKI 0.330 or less (16); dyslipidemia, total cholesterol, 200 mg/dl or more and/or HDL-cholesterol, 40 mg/dl or less, and/or LDL-cholesterol, 130 mg/dl or more, and/or triglycerides, 150 mg/dl or more.”
MethodInfluentialMen at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Ultrasound assessment of the polycystic ovary: international consensus definitions
Balen, A. H., Laven, J. S. E., Tan, S.-L., & Dewailly, D. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg044 · Cited by 1,015
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466 · cited 1×
“It is interesting to note that, in our patients with C-PCOS, the HDL-cholesterol levels were higher and the triglyceride levels were lower than those reported in other studies of women with PCOS ( 19 ).”
ResultDepartment of Obstetrics and Gynecology
(2015) · Juntendo Medical Journal · doi:10.14789/jmj.61.322 · Cited by 365
Carmina, E., & Lobo, R. A. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.01.041 · Cited by 294
Self-citationCarmina, E. (2003) · Human Reproduction · doi:10.1093/humrep/deg440 · Cited by 197
Self-citation
Research works printed but not linked: 1
- Zawdaki, 1992, Diagnostic criteria for polycystic ovary syndrome: toward a rationale approach, In: Dunaif A, Givens JR, Haseltine F, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;, 377
Cited by
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citationAzziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
“Contrast this with a recent multicenter trial at 22 sites in the United States in PCOS, where the BMI in the four treatment arms (total n ¼ 305) ranged from 35 to 38 kg/ m2 (219).”
BackgroundInfluentialSelf-citationAzziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citationDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Self-citationLim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939
Murri, M., Luque-Ramírez, M., Insenser, M., Ojeda-Ojeda, M., & Escobar-Morreale, H. F. (2013) · Human Reproduction Update · doi:10.1093/humupd/dms059 · Cited by 655
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
Escobar-Morreale, H. F., Luque-Ramírez, M., & González, F. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.11.036 · Cited by 517
Lipid Levels in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Wild, R. A., Rizzo, M., Clifton, S., & Carmina, E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.027 · Cited by 477
Self-citationBroekmans, F., Knauff, E., Valkenburg, O., Laven, J., Eijkemans, M., & Fauser, B. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01008.x · Cited by 442
Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature
Azziz, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2153 · Cited by 432
Carmina, E., Rosato, F., Jannì, A., Rizzo, M., & Longo, R. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1457 · Cited by 420
Self-citationImpact of Obesity on the Risk for Polycystic Ovary Syndrome
Yildiz, B. O., Knochenhauer, E. S., & Azziz, R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1834 · Cited by 401
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
Moran, L., & Teede, H. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp008 · Cited by 362
“tive and metabolic function in PCOS (Carmina et al., 2005).”
BackgroundInfluentialCarmina, E., Bucchieri, S., Esposito, A., Del Puente, A., Mansueto, P., Orio, F., Di Fede, G., & Rini, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2725 · Cited by 317
“Therefore, the studied patients presented the classic, more severe form of PCOS (32).”
BackgroundSelf-citationDeconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
Polycystic ovary syndrome and its developmental origins
Dumesic, D. A., Abbott, D. H., & Padmanabhan, V. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9046-0 · Cited by 283
Obesity and PCOS: Implications for Diagnosis and Treatment
Legro, R. (2012) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1328878 · Cited by 280
Diagnosis of Polycystic Ovarian Syndrome: In Defense of the Rotterdam Criteria
Franks, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2501 · Cited by 277
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Moghetti, P., Tosi, F., Bonin, C., Di Sarra, D., Fiers, T., Kaufman, J.-M., Giagulli, V. A., Signori, C., Zambotti, F., Dall'Alda, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3908 · Cited by 262
Welt, C. K., Gudmundsson, J. A., Arason, G., Adams, J., Palsdottir, H., Gudlaugsdottir, G., Ingadottir, G., & Crowley, W. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1327 · Cited by 261
Polycystic ovary syndrome and mitochondrial dysfunction
Zhang, J., Bao, Y., Zhou, X., & Zheng, L. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0509-4 · Cited by 258
Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome
Toulis, K. A., Goulis, D. G., Mintziori, G., Kintiraki, E., Eukarpidis, E., Mouratoglou, S.-A., Pavlaki, A., Stergianos, S., Poulasouchidou, M., Tzellos, T. G., et al. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr025 · Cited by 228
Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria
Shroff, R., Syrop, C. H., Davis, W., Van Voorhis, B. J., & Dokras, A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.01.032 · Cited by 214
Carmina, E., Napoli, N., Longo, R. A., Rini, G. B., & Lobo, R. A. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02058 · Cited by 203
Self-citationOligoanovulation with Polycystic Ovaries But Not Overt Hyperandrogenism
Dewailly, D., Catteau-Jonard, S., Reyss, A.-C., Leroy, M., & Pigny, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1054 · Cited by 198
“These data fit with previous reports indicating a trend toward higher insulin levels along with a higher degree of symptoms in women with PCO recruited either as normal volunteers (10) or via hyperandrogenic symptoms (24).”
ResultThe management of patients with polycystic ovary syndrome
Jayasena, C. N., & Franks, S. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.102 · Cited by 196
Jeanes, Y. M., & Reeves, S. (2017) · Nutrition Research Reviews · doi:10.1017/s0954422416000287 · Cited by 194
Mani, H., Levy, M. J., Davies, M. J., Morris, D. H., Gray, L. J., Bankart, J., Blackledge, H., Khunti, K., & Howlett, T. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12068 · Cited by 194
Diagnosis of Polycystic Ovary Syndrome
Chang, S., & Dunaif, A. E. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.002 · Cited by 189
Palomba, S., Falbo, A., Russo, T., Tolino, A., Orio, F., & Zullo, F. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.10.043 · Cited by 188
Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease
Guan, C., Zahid, S., Minhas, A. S., Ouyang, P., Vaught, A., Baker, V. L., & Michos, E. D. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.009 · Cited by 188
Meyer, M. L., Malek, A. M., Wild, R. A., Korytkowski, M. T., & Talbott, E. O. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr046 · Cited by 175
Diamanti‐Kandarakis, E., Katsikis, I., Piperi, C., Kandaraki, E., Piouka, A., Papavassiliou, A. G., & Panidis, D. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03247.x · Cited by 174
Panidis, D., Tziomalos, K., Misichronis, G., Papadakis, E., Betsas, G., Katsikis, I., & Macut, D. (2012) · Human Reproduction · doi:10.1093/humrep/der418 · Cited by 155
“However, the W was not reported in the single study that found higher insulin levels and lower QUICKI in normal weight women with phenotype 3 than in controls (Carmina et al., 2005) and it is possible that the former women had more pronounced abdominal adiposity despite the comparable BMI (Carmina et al.”
BackgroundResultBremer, A. A., & Miller, W. L. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.091 · Cited by 151
Orio, F., Palomba, S., Cascella, T., De Simone, B., Manguso, F., Savastano, S., Russo, T., Tolino, A., Zullo, F., Lombardi, G., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0965 · Cited by 149
Diamanti‐Kandarakis, E. (2006) · Endocrine · doi:10.1385/endo:30:1:13 · Cited by 147
Berni, T. R., Morgan, C. L., & Rees, D. A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab392 · Cited by 146
“Previous studies have suggested that cardiovascular risk factors are more prevalent in PCOS patients with irregular cycles (44), but additional studies are needed to establish whether this leads to differences among phenotypes in clinical events.”
BackgroundCorbould, A. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.872 · Cited by 144
Polycystic Ovary Syndrome and Oocyte Developmental Competence
Dumesic, D. A., Padmanabhan, V., & Abbott, D. H. (2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e31815e85fc · Cited by 144
Criteria, phenotypes and prevalence of polycystic ovary syndrome
Belenkaia, L. V., Лазарева, Л. М., Walker, W., Lizneva, D., & Сутурина, Л. В. (2019) · Minerva Obstetrics and Gynecology · doi:10.23736/s0026-4784.19.04404-6 · Cited by 144
Sprung, V. S., Atkinson, G., Cuthbertson, D. J., Pugh, C. J. A., Aziz, N., Green, D. J., Cable, N. T., & Jones, H. (2013) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04490.x · Cited by 142
Zhang, H., Zhu, F., Xiong, J., Shi, X., & Fu, S. (2009) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02347.x · Cited by 139
Diagnosis, phenotype, and prevalence of polycystic ovary syndrome
Carmina, E., & Azziz, R. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.012 · Cited by 137
Self-citationMorgan, C. L., Jenkins-Jones, S., Currie, C. J., & Rees, D. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1690 · Cited by 136
Enhanced Inflammatory Transcriptome in the Granulosa Cells of Women With Polycystic Ovarian Syndrome
Adams, J., Liu, Z., Ren, Y. A., Wun, W.-S., Zhou, W., Kenigsberg, S., Librach, C., Valdes, C., Gibbons, W., & Richards, J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4275 · Cited by 134
Adolescent Anovulation: Maturational Mechanisms and Implications
Rosenfield, R. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1770 · Cited by 134
Codner, E., Soto, N., Lopez, P., Trejo, L., Ávila, A., Eyzaguirre, F. C., Íniguez, G., & Cassorla, F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0108 · Cited by 129
Welt, C. K., Arason, G., Gudmundsson, J. A., Adams, J., Palsdóttir, H., Gudlaugsdóttir, G., Ingadóttir, G., & Crowley, W. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1191 · Cited by 127
Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women
Chae, S. J., Kim, J. J., Choi, Y. M., Hwang, K. R., Jee, B. C., Ku, S. Y., Suh, C. S., Kim, S. H., Kim, J. G., & Moon, S. Y. (2008) · Human Reproduction · doi:10.1093/humrep/den239 · Cited by 127
Guo, F., Gong, Z., Fernando, T., Zhang, L., Zhu, X., & Shi, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.892125 · Cited by 126
A 20-Year Follow-up of Young Women With Polycystic Ovary Syndrome
Carmina, E., Campagna, A. M., & Lobo, R. A. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31823f7135 · Cited by 125
Self-citationBerneis, K., Rizzo, M., Lazzaroni, V., Fruzzetti, F., & Carmina, E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1705 · Cited by 121
Self-citationOntogeny of the ovary in polycystic ovary syndrome
Dumesic, D. A., & Richards, J. S. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.02.011 · Cited by 120
Wiltgen, D., & Spritzer, P. M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.02.015 · Cited by 116
Carmina, E., Bucchieri, S., Mansueto, P., Rini, G., Ferin, M., & Løbo, R. A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.03.007 · Cited by 114
Self-citationHormones and cardiovascular health in women
The ESHRE Capri Workshop Group (2006) · Human Reproduction Update · doi:10.1093/humupd/dml028 · Cited by 106
Carmina, E., & Longo, R. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12185921 · Cited by 96
Self-citationChristakou, C. D., & Diamanti‐Kandarakis, E. (2008) · Women s Health · doi:10.2217/17455057.4.6.583 · Cited by 96
Fruzzetti, F., Perini, D., Lazzarini, V., Parrini, D., & Genazzani, A. R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.004 · Cited by 95
Amato, M. C., Verghi, M., Galluzzo, A., & Giordano, C. (2011) · Human Reproduction · doi:10.1093/humrep/der088 · Cited by 95
Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome
Berneis, K., Rizzo, M., Hersberger, M., Rini, G. B., Di Fede, G., Pepe, I., Spinas, G. A., & Carmina, E. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01897.x · Cited by 94
Self-citationPolycystic Ovary Syndrome in the Pediatric Population
Bremer, A. A. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0039 · Cited by 94
Yasmin, A., Roychoudhury, S., Choudhury, A. P., Ahmed, A. B. F., Dutta, S., Mottola, F., Verma, V., Kalita, J. C., Kumar, D., Sengupta, P., et al. (2022) · Life · doi:10.3390/life12121974 · Cited by 94
Carmina, E., & Løbo, R. A. (2022) · Diagnostics · doi:10.3390/diagnostics12102313 · Cited by 93
Self-citationIntrauterine Environment and Polycystic Ovary Syndrome
Goodarzi, M., Chazenbalk, G., Abbott, D., & Dumesic, D. (2014) · Seminars in Reproductive Medicine · doi:10.1055/s-0034-1371087 · Cited by 90
Carmina, E., Chu, M. C., Morán, C., Tortoriello, D. V., Vardhana, P. A., Tena, G., Preciado, R., & Løbo, R. A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.03.085 · Cited by 88
Self-citationMurphy, M. K., Hall, J. E., Adams, J. M., Lee, H., & Welt, C. K. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1085 · Cited by 85
Soares, G. M., Vieira, C. S., Martins, W. P., Franceschini, S. A., Dos Reis, R. M., Silva de Sá, M. F., & Ferriani, R. A. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03506.x · Cited by 83
Insulin Sensitivity after Metformin Suspension in Normal-Weight Women with Polycystic Ovary Syndrome
Palomba, S., Falbo, A., Russo, T., Manguso, F., Tolino, A., Zullo, F., De Feo, P., & Orio, F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0441 · Cited by 82
Graff, S. K., Mário, F. M., Alves, B. C., & Spritzer, P. M. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.06.005 · Cited by 79
Obesity and Lifestyle Management in Polycystic Ovary Syndrome
HOEGER, K. M. (2007) · Clinical Obstetrics and Gynecology · doi:10.1097/grf.0b013e31802f54c8 · Cited by 79
Not all women diagnosed with PCOS share the same cardiovascular risk profiles
Jovanovic, V. P., Carmina, E., & Løbo, R. A. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.021 · Cited by 78
Self-citationKollmann, M., Klaritsch, P., Martins, W. P., Guenther, F., Schneider, V., Herzog, S. A., Craciunas, L., Lang, U., Obermayer-Pietsch, B., Lerchbaum, E., et al. (2015) · Human Reproduction · doi:10.1093/humrep/dev187 · Cited by 77
The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum
Rosenfield, R. L. (2015) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2014.07.016 · Cited by 76
Cardiovascular risk in women with polycystic ovary syndrome
Giallauria, F., Orio, F., Palomba, S., Lombardi, G., Colao, A., & Vigorito, C. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32830b58d4 · Cited by 76
Farhadi‐Azar, M., Behboudi‐Gandevani, S., Rahmati, M., Mahboobifard, F., Pouya, E. K., Tehrani, F. R., & Azizi, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.825528 · Cited by 75
Silva, R. D. C., Pardini, D., & Kater, C. E. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200014 · Cited by 74
Jamil, A. S., Alalaf, S. K., Al-Tawil, N. G., & Al-Shawaf, T. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3889-5 · Cited by 73
“In fact, women with phenotype C PCOS were reported, on average, to be leaner than women with phenotype A PCOS, and their body weight was only slightly higher than in normal women [28], which was in agreement with our study.”
ResultA 20-Year Follow-up of Young Women With Polycystic Ovary Syndrome
Dungan, J. S. (2012) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/j.yobg.2012.06.193 · Cited by 72
Sahin, Y., Unluhizarci, K., Yilmazsoy, A., Yikilmaz, A., Aygen, E., & Kelestimur, F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02985.x · Cited by 67
Metabolic syndrome, diet and exercise
Sousa, S. M. C. D., & Norman, R. J. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.01.006 · Cited by 66
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
Torchen, L. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0956-2 · Cited by 65
Zueff, L. F. N., Martins, W. P., Vieira, C. S., & Ferriani, R. A. (2012) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.10084 · Cited by 63
The Prevalence of Metabolic Syndrome in the Different Phenotypes of Polycystic Ovarian Syndrome
Tavares, A., & Barros, R. C. D. R. (2019) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0038-1676568 · Cited by 61
Diagnostic Criteria for Polycystic Ovarian Syndrome
Broekmans, F. J., & Fauser, B. C. J. M. (2006) · Endocrine · doi:10.1385/endo:30:1:3 · Cited by 59
Tosi, F., Dorizzi, R., Castello, R., Maffeis, C., Spiazzi, G., Zoppini, G., Muggeo, M., & Moghetti, P. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0379 · Cited by 56
Carmina, E., & Løbo, R. A. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347408 · Cited by 55
Self-citationImbalanced circulating matrix metalloproteinases in polycystic ovary syndrome
Gomes, V. A., Vieira, C. S., Jacob‐Ferreira, A. L., Belo, V. D. A., Soares, G. M., Fernandes, J. B. F., Ferriani, R. A., & Tanus-Santos, J. E. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0793-6 · Cited by 55
Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome
Lambrinoudaki, I. V. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.09.005 · Cited by 54
Vine, D., Ghosh, M., Wang, T., & Bakal, J. (2024) · CJC Open · doi:10.1016/j.cjco.2023.12.010 · Cited by 53
“65,66 65-67 In gene-wide association studies, cross-trait analysis has shown that obesity-related traits and body mass index share a genetic basis with PCOS.”
BackgroundThe spectrum of androgen excess disorders
Carmina, E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.02.069 · Cited by 53
Self-citationHassa, H., Tanir, H. M., & Yıldız, Z. (2006) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-006-0173-8 · Cited by 53
Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome
Hutchison, S. K., Harrison, C., Stepto, N., Meyer, C., & Teede, H. J. (2008) · Diabetes Care · doi:10.2337/dc07-2265 · Cited by 51
Lerchbaum, E., Theiler‐Schwetz, V., Giuliani, A., & Obermayer-Pietsch, B. M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1035 · Cited by 51
Metadata
- Authors
- Carmina, E., Chu, M. C., Longo, R. A., Rini, G. B., & Lobo, R. A.
- Affiliations
- University of Palermo (IT)
- Columbia University (US)
- Department of Obstetrics and Gynecology (M.C.C., R.A.Lob.), Columbia University, New York, New York 10032-3784
- ORCID
- Carmina, E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-05-01
- Volume
- 90
- Issue
- 5
- Pages
- 2545-2549
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2030643176
- Cited by
- 274
- References
- 21
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 1 · 2023: 10 · 2022: 10 · 2021: 9 · 2020: 2 · 2019: 8 · 2018: 6 · 2017: 10 · 2016: 16 · 2015: 11 · 2014: 15 · 2013: 15 · 2012: 16
- FWCI
- 27.36
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, hyperandrogenism, insulin resistance, obesity, dyslipidemia, cardiovascular risk factors, C-reactive protein, homocysteine, QUICKI, metabolic risk, phenotypic classification, androgen levels, gonadotropins, body mass index
- MeSH terms
- C-Reactive Protein, Cardiovascular Diseases, Female, Humans, Insulin, Insulin Resistance, Luteinizing Hormone, Cholesterol, LDL, Phenotype, Polycystic Ovary Syndrome, Risk Factors, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.